Rankings
▼
Calendar
PHIO Q4 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$45,000
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-46.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$26,000
Balance Sheet
Total Assets
$16M
Total Liabilities
$3M
Stockholders' Equity
$13M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$45,000
-$16,000
-181.3%
Operating Income
-$2M
-$3M
+7.8%
Net Income
-$2M
-$3M
+7.4%
← FY 2020
All Quarters
Q1 2021 →